Aminoalkylphosphonates and related compounds as edg receptor agonists

The present invention encompasses compounds of formula (II); as well as the pharmaceutically acceptable salts and hydrates thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. Pharmaceutical compositions a...

Full description

Saved in:
Bibliographic Details
Main Authors DOHERTY GEORGE A, HALE JEFFREY J
Format Patent
LanguageEnglish
Published 19.05.2005
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention encompasses compounds of formula (II); as well as the pharmaceutically acceptable salts and hydrates thereof. The compounds are useful for treating immune mediated diseases and conditions, such as bone marrow, organ and tissue transplant rejection. Pharmaceutical compositions and methods of use are included.
Bibliography:Application Number: US20040505268